Edition:
United Kingdom

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

18.46USD
13 Dec 2017
Change (% chg)

$0.02 (+0.11%)
Prev Close
$18.44
Open
$18.45
Day's High
$18.86
Day's Low
$18.29
Volume
50,608
Avg. Vol
60,263
52-wk High
$25.09
52-wk Low
$14.79

Latest Key Developments (Source: Significant Developments)

Atricure reports Q3 loss per share $0.22
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Atricure :Atricure reports third quarter 2017 financial results.Q3 revenue $42.2 million versus I/B/E/S view $43.4 million.Q3 loss per share $0.22.Sees FY 2017 revenue up about 11 to 13 percent.Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.Atricure Inc - for 2017 ‍net loss per share is projected to be in range of $0.94 to $1.04​.Atricure Inc - ‍company continues to expect positive adjusted EBITDA for full year 2018​.  Full Article

Atricure sees FY 2016 revenue up about 20 to 22 percent
Thursday, 4 Aug 2016 

Atricure Inc : Atricure reports second quarter 2016 financial results . Sees fy 2016 revenue up about 20 to 22 percent . Q2 earnings per share view $-0.30 -- Thomson Reuters I/B/E/S . Q2 revenue $39.7 million versus i/b/e/s view $39.8 million . Q2 loss per share $0.26 .Fy2016 revenue view $160.5 million -- Thomson Reuters I/B/E/S.  Full Article

AtriCure, Inc announces $25 mln term loan
Thursday, 28 Apr 2016 

AtriCure, Inc:Says has entered into an amended and restated term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to a new $25 mln five-year term loan, as well as renewing a $15 million revolving line of credit.  Full Article

AtriCure Inc updates FY 2016 guidance
Monday, 11 Jan 2016 

AtriCure Inc:Projects FY 2016 revenue growth of about 25 pct. over FY 2015 at current exchange rates.Expects FY 2016 adjusted EBITDA, a non-GAAP measure, is projected to be a loss in the range of $14 to $15 million.  Full Article

BRIEF-Atricure reports Q3 loss per share $0.22

* Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S